You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Response to: ‘Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features’ by Araki et al
  1. Alfred Franzblau1,
  2. Vinicius C Antao2,
  3. Germania Pinheiro3,
  4. Theodore Larson3
  1. 1 School of Public Health, University of Michigan, Ann Arbor, Michigan, USA
  2. 2 Healthcare Research Institute, Hospital for Special Surgery, New York City, New York, USA
  3. 3 Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, USA
  1. Correspondence to Dr Alfred Franzblau; afranz{at}umich.edu

http://dx.doi.org/10.1136/oemed-2017-104640

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The report by Araki et al is important for a number of reasons, most significantly that it is the first-ever study of pleural abnormalities potentially related to asbestos in a large, general population (the Framingham Heart Study (FHS) Third Generation cohort) that is based on chest CT scans rather than chest radiographs.1 Pleural abnormalities were reported to be present in 1.5% of the study population. A key conclusion of the study was that the prevalence of pleural abnormalities in the present study was significantly lower than …

    View Full Text

    Footnotes

    • Contributors Each author has participated sufficiently in this submission to take public responsibility for its content. Publication has been approved by all authors.

    • Competing interests AF has served as an expert witness in asbestos litigation.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles